Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiwen Yu

Showing results (11-20 of 42) with videos related to

Pageof 5
Sort By:
Scientific Reports|July 10, 2023
Mitogen activated protein kinase phosphatase 5 alleviates liver ischemia-reperfusion injury by inhibiting TAK1/JNK/p38 pathwayQiwen Yu, Sanyang Chen, Jiye Li, et al.
Translational Lung Cancer Research|August 25, 2021
Hyperprogression under immunotherapy: a new form of immunotherapy response?-a narrative literature reviewMiaozhen Lin, Ben G L Vanneste, Qiwen Yu, et al.
Cell Death & Disease|June 30, 2023
KLF6 alleviates hepatic ischemia-reperfusion injury by inhibiting autophagyJiye Li, Dongsheng Yu, Chenhui He, et al.
Sensors (Basel, Switzerland)|May 28, 2020
A Highly Sensitive Amperometric Glutamate Oxidase Microbiosensor Based on a Reduced Graphene Oxide/Prussian Blue Nanocube/Gold Nanoparticle Composite Film-Modified Pt ElectrodeJing Chen, Qiwen Yu, Wei Fu, et al.
Anesthesia and Analgesia|May 25, 2019
Evaluating Propofol Concentration in Blood From Exhaled Gas Using a Breathing-Related Partition CoefficientHao Dong, Fengjiang Zhang, Jing Chen, et al.
Annals of Surgical Oncology|October 27, 2025
ASO Author Reflections: EMC3 in HCC-A Novel Regulator of PI3K/AKT/mTOR Signaling and Tumor ImmunityAn Zhao, Changjun Huang, Minghao Li, et al.
Annals of Surgical Oncology|November 5, 2025
EMC3 as a Novel Biomarker and Driver of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma ProgressionAn Zhao, Changjun Huang, Minghao Li, et al.
Scientific Reports|April 12, 2024
Phosphoglycerate mutase 5 exacerbates liver ischemia-reperfusion injury by activating mitochondrial fissionHongwei Tang, Qiwen Yu, Xu Chen, et al.
Annals of Surgical Oncology|January 6, 2026
Correction: EMC3 as a Novel Biomarker and Driver of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma ProgressionAn Zhao, Changjun Huang, Minghao Li, et al.
Molecular Medicine Reports|July 23, 2021
miR‑140‑5p alleviates mouse liver ischemia/reperfusion injury by targeting CAPN1Qiwen Yu, Sanyang Chen, Hongwei Tang, et al.
Pageof 5

Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Scientific Reports|July 10, 2023
Mitogen activated protein kinase phosphatase 5 alleviates liver ischemia-reperfusion injury by inhibiting TAK1/JNK/p38 pathwayQiwen Yu, Sanyang Chen, Jiye Li, et al.
Translational Lung Cancer Research|August 25, 2021
Hyperprogression under immunotherapy: a new form of immunotherapy response?-a narrative literature reviewMiaozhen Lin, Ben G L Vanneste, Qiwen Yu, et al.
Cell Death & Disease|June 30, 2023
KLF6 alleviates hepatic ischemia-reperfusion injury by inhibiting autophagyJiye Li, Dongsheng Yu, Chenhui He, et al.
Sensors (Basel, Switzerland)|May 28, 2020
A Highly Sensitive Amperometric Glutamate Oxidase Microbiosensor Based on a Reduced Graphene Oxide/Prussian Blue Nanocube/Gold Nanoparticle Composite Film-Modified Pt ElectrodeJing Chen, Qiwen Yu, Wei Fu, et al.
Anesthesia and Analgesia|May 25, 2019
Evaluating Propofol Concentration in Blood From Exhaled Gas Using a Breathing-Related Partition CoefficientHao Dong, Fengjiang Zhang, Jing Chen, et al.
Annals of Surgical Oncology|October 27, 2025
ASO Author Reflections: EMC3 in HCC-A Novel Regulator of PI3K/AKT/mTOR Signaling and Tumor ImmunityAn Zhao, Changjun Huang, Minghao Li, et al.
Annals of Surgical Oncology|November 5, 2025
EMC3 as a Novel Biomarker and Driver of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma ProgressionAn Zhao, Changjun Huang, Minghao Li, et al.
Scientific Reports|April 12, 2024
Phosphoglycerate mutase 5 exacerbates liver ischemia-reperfusion injury by activating mitochondrial fissionHongwei Tang, Qiwen Yu, Xu Chen, et al.
Annals of Surgical Oncology|January 6, 2026
Correction: EMC3 as a Novel Biomarker and Driver of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma ProgressionAn Zhao, Changjun Huang, Minghao Li, et al.
Molecular Medicine Reports|July 23, 2021
miR‑140‑5p alleviates mouse liver ischemia/reperfusion injury by targeting CAPN1Qiwen Yu, Sanyang Chen, Hongwei Tang, et al.
Pageof 5